Search Results 331-340 of 18840 for Neutrophil

  1. A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

    No cytopenias (platelets < 100,000/µl, hemoglobin < 10 g/dl, or absolute neutrophil count < 1500/µl). Exclusion Criteria: The following criteria will prevent ...

  2. A Study to Evaluate Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration In HPV Head And Neck Cancer - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥100,000/mm^3;; Hemoglobin ≥8.0g/dL;; Creatinine ≤ 1.5 mg/dL or creatinine clearance ≥ 50 mL ...

  3. A Study to Evaluate Clazakizumab in Patients with Life-threatening COVID-19 Infection (Enrolling by Invitation Only) - Mayo Clinic

    Neutrophil-Lymphocyte Ratio > 4;; LDH > 200 U/L;; Increase in troponin in patient w/out known cardiac disease. Has a consent designee willing to provide ...

  4. A Study to Evaluate Pembrolizumab for Surgically Treated Adjuvant Merkel Cell Carcinoma - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1000/uL: ANC: ______ Date Obtained: ______. Platelets ≥ 75 x 103/uL: Platelet: ______ Date Obtained ...

  5. Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome - Mayo Clinic

    Absolute neutrophil count (ANC) >= 1500/mm^3; Platelet count (PLT) >= 100,000/mm^3; Creatinine =< 2 x upper limit of normal (ULN); Either serum glutamate ...

  6. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

    An absolute neutrophil count of <1000 cells/μL during screening. Known or suspected current (< 90 days) illicit drug use. Note: marijuana use is allowed ...

  7. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    Absolute neutrophil count > 1.5 × 109/L (1500/mm3);; Platelets > 100 × 109/L (100000/mm3);; Hemoglobin ≥ 10.0 g/dL (6.2 mmol/L);; Serum total bilirubin ≤ 1.5 ...

  8. Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma - Mayo Clinic

    Absolute neutrophil count (ANC) < 1,000/mm3 without growth factor support within 7 days prior to testing; Platelet count < 75,000 mm3 without transfusion ...

  9. Study of BLU-667 in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors - Mayo Clinic

    Absolute neutrophil count (ANC) < 1.0 × 109/L;; Hemoglobin < 9.0 g/dL (red blood cell transfusion and erythropoietin may be used to reach at least 9.0 g/dL ...

  10. Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The Investigational Device Uses Iron Oxide Nanoparticles Together With Non-Ionizing Alternating Magnetic Field To Generate Heat And Destroy Tumors - Mayo Clinic

    Leukocytes ≥3,000/mcL Absolute neutrophil count ≥1,500/mcL Platelets ≥100,000/mcL Total bilirubin ≤ 2.5 x limit of normal (ULN) AST(SGOT)/ALT(SGPT) ≤5 ...